IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Richesm Healthcare IPO is a book build IPO listing on BSE SME exchange. The company is based in New Delhi and caters to Healthcare - Personal Care sector. Khandwala Securities is the merchant banker of Richesm Healthcare IPO. It is a SME UPCOMING IPO which filed its Draft Red Herring Prospectus (DRHP) on 1st August 2024.
Richesm Healthcare IPO posted revenues of Rs 86.03 crores and PAT of Rs 17.40 crores in FY25 on annualised basis.Financial results of Richesm Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Richesm Healthcare IPO PAT Margin is 20.23%, ROCE (Return on Capital Employed) is 49.17% as per latest financial. The below table shows Richesm Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Richesm Healthcare IPO is Rs [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Richesm Healthcare IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Richesm Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Richesm Healthcare IPO is ₹[●] Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Richesm Healthcare IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Richesm Healthcare IPO reported revenue of ₹86.03 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Richesm Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Richesm Healthcare recorded an EBITDA of ₹ 18.08 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Richesm Healthcare Profit After Tax (PAT) is ₹17.40 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 86.02 Cr.
EBITDA Margin:
21.02
%
Net Worth: ₹ 29.76 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: 0.25 times
Richesm Healthcare operates in Healthcare - Personal Care and . The Issue is listed on BSE SME in Apr, 2025. Richesm Healthcare IPO size was with Issue price of .
Merchant Banker(s) of Richesm Healthcare IPO: Khandwala Securities Limited
Richesm Healthcare IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Richesm Healthcare IPO listed at a listing price of against the offer price of .
The current market price of Richesm Healthcare is .
Why Us?
